JP2024538258A5 - - Google Patents

Info

Publication number
JP2024538258A5
JP2024538258A5 JP2024525118A JP2024525118A JP2024538258A5 JP 2024538258 A5 JP2024538258 A5 JP 2024538258A5 JP 2024525118 A JP2024525118 A JP 2024525118A JP 2024525118 A JP2024525118 A JP 2024525118A JP 2024538258 A5 JP2024538258 A5 JP 2024538258A5
Authority
JP
Japan
Prior art keywords
cells
population
antigen
tim3
lag3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024525118A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024538258A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/080008 external-priority patent/WO2023073062A1/en
Publication of JP2024538258A publication Critical patent/JP2024538258A/ja
Publication of JP2024538258A5 publication Critical patent/JP2024538258A5/ja
Pending legal-status Critical Current

Links

JP2024525118A 2021-10-26 2022-10-26 高機能性自己幹由来のt細胞免疫療法 Pending JP2024538258A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21306493 2021-10-26
EP21306493.4 2021-10-26
PCT/EP2022/080008 WO2023073062A1 (en) 2021-10-26 2022-10-26 T cell immunotherapy derived from highly functional autologous stem

Publications (2)

Publication Number Publication Date
JP2024538258A JP2024538258A (ja) 2024-10-18
JP2024538258A5 true JP2024538258A5 (cg-RX-API-DMAC7.html) 2025-11-04

Family

ID=78709377

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024525118A Pending JP2024538258A (ja) 2021-10-26 2022-10-26 高機能性自己幹由来のt細胞免疫療法

Country Status (7)

Country Link
US (1) US20250017961A1 (cg-RX-API-DMAC7.html)
EP (1) EP4423247A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024538258A (cg-RX-API-DMAC7.html)
CN (1) CN118251487A (cg-RX-API-DMAC7.html)
AU (1) AU2022374955A1 (cg-RX-API-DMAC7.html)
CA (1) CA3235307A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023073062A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026514981A (ja) * 2023-04-26 2026-05-13 ユニヴェルシテ パリ-サクレー 自己幹細胞メモリーt細胞由来のt細胞免疫療法
WO2025210263A1 (en) 2024-04-05 2025-10-09 Assistance Publique - Hôpitaux De Paris T cell immunotherapy of cutaneous diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10829735B2 (en) * 2015-07-21 2020-11-10 The Trustees Of The University Of Pennsylvania Methods for improving the efficacy and expansion of immune cells
KR20180099768A (ko) * 2015-12-30 2018-09-05 노파르티스 아게 증진된 효능을 갖는 면역 이펙터 세포 요법
EP3701041A4 (en) * 2017-10-27 2021-11-17 The Trustees of The University of Pennsylvania METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASES ASSOCIATED WITH EXHAUSTED T-CELLS

Similar Documents

Publication Publication Date Title
AU738538B2 (en) Method for the production of selected lymphocytes
Schultze et al. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy.
JP2022066355A (ja) 免疫療法向けのt細胞組成物
US20250084145A1 (en) Method for establishing pluripotent stem cells bearing genes encoding antigen specific t cell receptor
Zuliani et al. Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy
CN112574952B (zh) 一种工程化人体免疫细胞、其制备方法及应用
CN107922925A (zh) 用于自然杀伤细胞扩增的方法
TWI410495B (zh) 新穎之人類t細胞群
CN115558641B (zh) 高纯度效应免疫细胞群及其培养方法、试剂组合物和应用
JP5856025B2 (ja) 単球またはnk細胞を入手する方法
CN109082410A (zh) 外周血单个核细胞诱导的记忆性免疫细胞及应用
CN108588022A (zh) 体外培养富集人cd4+和cd8+ tcm细胞的方法
EP3936611A1 (en) Composition, culture medium and method for inducing and/or amplifying tscm in vitro
CN116063449A (zh) 一种制备肿瘤抗原特异性t细胞的方法
CN115094034A (zh) 一种人nkt细胞系及其应用
CN109957543A (zh) 利用脐带血大量扩增脐血nk细胞的方法
JPWO2021100585A5 (cg-RX-API-DMAC7.html)
CN114854685B (zh) 一种肿瘤特异性ctl细胞制备的工艺方法
CN103911341B (zh) Th1细胞亚群的制备方法及其在制备抗肿瘤细胞制剂中的应用
CN110129374B (zh) 一种rfft细胞的构建方法
CN109280643B (zh) 一种rfft细胞
CN109294995B (zh) 一种rfft1细胞
Shevchenko et al. In Vitro Model of Suppression of the Alloantigen Response by Tolerogenic Dendritic Cells Transfected with Personalized DNA Constructs Encoding HLA Epitopes
Lu et al. In vitro assessment of polysaccharides immunoregulatory effects on CD3+ CD56+ NKT-like cells
Shih et al. Clinical-scale 10-day TCR-T cell manufacturing using IL-2/7/15 and TGF-β promotes early memory and tissue-resident-like phenotypes and robust antitumor activity in vitro